HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kimberley E Hewitt Selected Research

Ligands

9/2006Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kimberley E Hewitt Research Topics

Disease

1Peripheral Nervous System Diseases (PNS Diseases)
06/2018
1Leukemia
09/2006
1Neoplasms (Cancer)
09/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2006

Drug/Important Bio-Agent (IBA)

1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2006
1LigandsIBA
09/2006
1OligonucleotidesIBA
09/2006
1Proteins (Proteins, Gene)FDA Link
09/2006
1Messenger RNA (mRNA)IBA
09/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2006
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
09/2006
1Antisense OligonucleotidesIBA
09/2006
1Taxoids (Taxanes)IBA
09/2006
1AEG 35156IBA
09/2006
1X-Linked Inhibitor of Apoptosis ProteinIBA
09/2006
1Docetaxel (Taxotere)FDA Link
09/2006

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2018 - 09/2006